China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial
Release time：2024-05-18 00:33:31 Source：Culture Capsule news portal
-
Contact Us
- Home
- News
- People
- In-depth
- ACWF
- 2023 Women Science and Technology Innovation Pioneer...
- People Enjoy Blooming Tulips in Jinan, East...
- Flowers Bloom Across China in Spring
China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial
September 1, 2022 |
| A nurse shows human papillomavirus (HPV) vaccines developed by Chinese researchers at the provincial Maternity and Child Healthcare Hospital in Wuhan, central China's Hubei Province, May 18, 2020. [Xinhua/Xiong Qi] |
BEIJING, Aug. 30 (Xinhua) — A recent study has found that China's first self-developed HPV vaccine Cecolin can offer women adults full immunity against two types of human papillomavirus (HPV).
A group of Chinese researchers analyzed data from 66-month follow-up visits as a part of the bivalent vaccine's Phase 3 clinical trial and found that its efficacy against high-grade genital lesions, typical symptoms of cervical cancer, reached 100 percent.
Furthermore, the E coli-produced HPV 16/18 recombinant vaccine realized a 97 percent efficacy against persistent HPV infections, according to the study published in the journal Lancet Infectious Diseases.
The clinical trial included 7,372 healthy women aged 18 to 45, with 3,689 in the vaccinated group and 3,683 in the control group. The cumulative incidence in the vaccinated group was noticeably lower than that in the control group, according to the study.
Cecolin is jointly developed by Xiamen University and Xiamen Innovax, making China the third country in the world to attain an independent cervical cancer vaccine supply after the United States and the United Kingdom. It earned the World Health Organization Prequalification in October 2021.
(Source: Xinhua)
32.3KPlease understand that womenofchina.cn,a non-profit, information-communication website, cannot reach every writer before using articles and images. For copyright issues, please contact us by emailing: [email protected]. The articles published and opinions expressed on this website represent the opinions of writers and are not necessarily shared by womenofchina.cn.
Comments
Magazines
Projects
Photos
Special Coverage
- Previous：The Biden administration is planning more changes to quicken asylum processing for new migrants
- Next：Human rights group urges Thailand to stop forcing dissidents to return home
Related articles
- Asian soccer body scraps 12
- 2025 Asian Winter Games to highlight environmental protection, technology
- Chen Chunyan: 'Liusanjie of New Generation' Sings for New Era
- Headmistress Committed to Primary School Education for Decades
- Protests are planned in Serbia against a real estate project financed by Trump's son
- Working Hard During Golden Time
- Tujia Woman Promotes Ethnic Culture Through Literature, Songs
- Restorer's Hands
- Houston storms: At least 4 killed, power cut in 900,000 homes
- Yang Yang Set for Re
- HKSAR government denounces U.S. consul general's remarks on security law in Hong Kong
- Rural Woman Painter Relishes Showing Her True Colors
- Let 'Young Flowers' Blossom in Village
- Women Promotes Lahu Culture, Helps Villagers Achieve Prosperity by Singing, Dancing
- Arkansas Supreme Court upholds 2021 voting restrictions that state judge found unconstitutional
- Guangzhou, Shanghai take lead in CBA playoffs
- Book Restorers Touch History
- Rural Delegate Wears Many Hats Serving Villagers
- Former Connecticut budget official arrested, pleads not guilty to bribery and extortion charges
- Entrepreneur Helps Rural Women Shake off Poverty in Northwest China
Random recommendation
- Copyright © 2024 Powered by China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial ,Culture Capsule news portal sitemap